T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Intel
INTC
|
+$1.59B |
| 2 |
Dollar General
DG
|
+$1.53B |
| 3 |
Charles Schwab
SCHW
|
+$1.19B |
| 4 |
Uber
UBER
|
+$971M |
| 5 |
Nike
NKE
|
+$868M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$2.83B |
| 2 |
Amazon
AMZN
|
+$2.33B |
| 3 |
NVIDIA
NVDA
|
+$1.75B |
| 4 |
Humana
HUM
|
+$1.46B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
Sector Composition
| 1 | Technology | 31.18% |
| 2 | Healthcare | 15.82% |
| 3 | Financials | 11.11% |
| 4 | Consumer Discretionary | 10.8% |
| 5 | Communication Services | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1051
NCR Voyix
VYX
$1.73B
| $12.4M | ﹤0.01% |
730,779
-825,167
| -53% | -$14M |
|
1052
Palomar
PLMR
$3.18B
| $12.2M | ﹤0.01% |
219,068
-119,165
| -35% | -$6.61M |
|
1053
Extreme Networks
EXTR
$2.96B
| $12.2M | ﹤0.01% |
688,748
-326,706
| -32% | -$5.76M |
|
1054
BWX Technologies
BWXT
$15.2B
| $12.1M | ﹤0.01% |
158,254
-6,246
| -4% | -$479K |
|
1055
United Parks & Resorts
PRKS
$2.77B
| $12.1M | ﹤0.01% |
228,852
-2,532
| -1% | -$134K |
|
1056
Cabaletta Bio
CABA
$159M
| $12M | ﹤0.01% |
527,765
+512,450
| +3,346% | +$11.6M |
|
1057
First Citizens BancShares
FCNCA
$25.4B
| $11.9M | ﹤0.01% |
8,404
+2,209
| +36% | +$3.13M |
|
1058
American Airlines Group
AAL
$8.54B
| $11.9M | ﹤0.01% |
866,648
+3,520
| +0.4% | +$48.4K |
|
1059
CI&T Inc
CINT
$676M
| $11.8M | ﹤0.01% |
2,239,515
-40,372
| -2% | -$212K |
|
1060
Darling Ingredients
DAR
$4.95B
| $11.7M | ﹤0.01% |
235,408
-3,143,413
| -93% | -$157M |
|
1061
Tapestry
TPR
$21.9B
| $11.7M | ﹤0.01% |
318,625
-7
| -0% | -$258 |
|
1062
Exponent
EXPO
$3.5B
| $11.7M | ﹤0.01% |
133,069
-165,578
| -55% | -$14.6M |
|
1063
Axsome Therapeutics
AXSM
$6.14B
| $11.7M | ﹤0.01% |
146,557
+123,949
| +548% | +$9.87M |
|
1064
Omnicell
OMCL
$1.53B
| $11.6M | ﹤0.01% |
307,222
-3,676
| -1% | -$138K |
|
1065
Campbell Soup
CPB
$9.98B
| $11.5M | ﹤0.01% |
265,823
+9,702
| +4% | +$419K |
|
1066
Generation Bio
GBIO
$40.3M
| $11.4M | ﹤0.01% |
692,617
-52,853
| -7% | -$872K |
|
1067
Cadre Holdings
CDRE
$1.28B
| $11.4M | ﹤0.01% |
346,778
+28,390
| +9% | +$934K |
|
1068
Markel Group
MKL
$24.3B
| $11.3M | ﹤0.01% |
7,977
+373
| +5% | +$530K |
|
1069
Novartis
NVS
$247B
| $11.3M | ﹤0.01% |
112,153
-1,261
| -1% | -$127K |
|
1070
Enovis
ENOV
$1.81B
| $11.3M | ﹤0.01% |
201,842
+172,468
| +587% | +$9.66M |
|
1071
Immunome
IMNM
$783M
| $11.2M | ﹤0.01% |
1,051,222
+877,592
| +505% | +$9.39M |
|
1072
Franklin Resources
BEN
$12.6B
| $11.2M | ﹤0.01% |
377,304
-503
| -0.1% | -$15K |
|
1073
Valmont Industries
VMI
$7.45B
| $11.1M | ﹤0.01% |
47,502
+390
| +0.8% | +$91.1K |
|
1074
StepStone Group
STEP
$4.99B
| $10.8M | ﹤0.01% |
340,180
+70,315
| +26% | +$2.24M |
|
1075
PennyMac Financial
PFSI
$6.22B
| $10.8M | ﹤0.01% |
122,177
-6,975
| -5% | -$616K |
|